發送短信 : Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: A phase III trial

 _    _     _____    _    _    __   __    ______  
| || | ||  |  ___|| | |  | ||  \ \\/ //  /_____// 
| || | ||  | ||__   | |/\| ||   \ ` //   `____ `  
| \\_/ ||  | ||__   |  /\  ||    | ||    /___//   
 \____//   |_____|| |_// \_||    |_||    `__ `    
  `---`    `-----`  `-`   `-`    `-`'    /_//     
                                         `-`